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Abstract Superobese patients (SO) (body mass index
(BMI)≥50 kg/m2) represent a real surgical challenge and
the best management remains debatable. While the safety of
a laparoscopic approach has been questioned for this popu-
lation, robotics has been introduced in the armamentarium
of the bariatric surgeon, yet its role remains poorly assessed,
especially for a very high BMI. The study aim is thus to
report our experience with robot-assisted Roux-en-Y gastric
bypass (RYGB) for SO. From July 2006 to May 2012, 288
consecutive robot-assisted RYGB procedures have been
performed at a single institution. All data were collected
prospectively in a dedicated database. Among those
patients, 41 were SO (14.2 %). All the peri- and postoper-
ative parameters were compared to the morbidly obese
(MO) group (BMI<50). Data have been reviewed retrospec-
tively. The SO group presented a higher ASA score and
more male patients. The operative time was similar between
both groups, yet there were more conversions in the SO
group (two versus one for MO; p00.05). The morbidity and
mortality rates were similar between both groups. The
length of stay was longer for the SO population (7 vs.
6 days; p00.03). The percent BMI loss was similar at
1 year (34 vs. 34 %; p01), but the percent excess BMI
loss was higher for the MO group (83 vs. 65 % for the
SO group; p00.0007). Robot-assisted RYGB can be
performed safely for SO, with complication rates and
functional results at 1 year comparable to MO, yet this
approach for SO has been associated with a slightly
increased conversion rate and length of stay.
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Introduction
Obesity is a worldwide health problem, and its management
concerns all the medical and surgical fields. The superobese
patients (SO) are a special category of patients with a body
mass index (BMI) superior or equal to 50 kg/m2. The
management of this population remains a challenge [1]. In
addition, there is no real consensus concerning the surgical
procedure to perform for SO [2]. For morbidly obese (MO;
BMI<50) patients, laparoscopic Roux-en-Y gastric bypass
(RYGB) is considered as the gold standard surgical proce-
dure by many specialists [3, 4]. The overall results have
been shown to be very good not only in terms of weight loss
but also in terms of improvement of comorbidities [5], yet in
the case of SO, the surgical and anesthesiological approach
becomes more challenging. This fragile population has
benefited from different procedures: sleeve gastrectomy,
duodenal switch, gastric banding, and RYGB have all been
reported as relatively safe [1, 6–12].
While these procedures can and should be performed by
a minimally invasive approach, it remains challenging as it
requires advanced laparoscopic skills. The introduction of
robotics in the armamentarium of the bariatric surgeon has
been seen by several groups as a real improvement [13–16].
The technical advantages of robotic technology have led to a
diminution of anastomotic complications after RYGB, for
example, as reported by several authors [14, 15, 17]. For SO
patients, sleeve gastrectomy and duodenal switch have been
performed safely by a robotic approach as well [18, 19], but
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specific results for RYGB in those very high BMI patients
are difficult to find.
The study aim was thus to report our experience with
robot-assisted RYGB for SO patients, comparing these
results to the MO population.
Materials and Methods
From July 2006 to May 2012, 288 consecutive robot-
assisted RYGB were performed at a single institution.
Among the 288 robot-assisted RYGB, 41 were performed
for SO (14.2 %).
All of the procedures were performed by four different
experienced laparoscopic and robotic surgeons (>100 ad-
vanced cases of minimally invasive surgery each) using the
same standardized hybrid technique as already described
thoroughly elsewhere [13, 20]. Patients included in the
bariatric program met the criteria of the Swiss Society for
the Study of Morbid Obesity and Metabolic Disorders [21].
All of those patients were eligible for a robotic approach and
there were no selection criteria specific for robotics. The
exclusion criteria were the same as for laparoscopy (anes-
thesiological contraindication, evident hostile abdomen)
[20]. Data were entered prospectively into a dedicated bari-
atric database and retrospectively reviewed. Follow-up was
organized by a research nurse especially dedicated to the
bariatric program according to our national guidelines.
Variables
A SO was defined as a patient with a BMI≥50 kg/m2. The
MO group consisting of 247 patients (85.8 %) was defined
as patients with a BMI<50. The operative time was defined
as the time between the first skin incision and the last skin
closure. A conversion was defined as the need to terminate
the procedure by an approach other than robotic (laparosco-
py or open). The percent of BMI loss (%BMI loss) was
defined as the operative BMI minus the follow-up BMI
divided by the operative BMI [22]. The percent of excess
BMI loss (%EBMIL) was defined as: 100− ((follow up
BMI−25)/(beginning BMI−25)×100), where 25 is defined
as the limit of a normal BMI [22].
Statistics
The results of parametric and nonparametric data were
expressed as mean±standard deviation (SD) and median
(range), respectively. GraphPad Software (GraphPad, La
Jolla, CA, USA) was used for all statistical analyses. Con-
fidence intervals were set at 95 %. A two-sided P value of≤
0.05 was considered as statistically significant. Compari-
sons between both groups were determined using Fisher's
exact test for discrete variables and Student's t-test for con-
tinuous variables.
Results
During the study period, 41 SO underwent a robot-assisted
RYGB. The MO group consisted of 247 patients. The clin-
ical data of both groups are summarized in Table 1.
When comparing the population of SO group and MO
group, there were statistically significant differences: there
were more male patients in the SO group (41.5 vs. 22.7 % for
MO; p00.02), and the American Society of Anesthesiologists
(ASA) score was higher for this group as well (2.46 vs. 2; p0
0.001). Concerning comorbidities, there was no difference.
For the operative data (Table 2), the operative time has
been shown to be similar between both groups, yet there
were more conversions in the SO group (4.9 vs. 0.4 % for
MO; p00.05). In the SO group, we noticed two conver-
sions: one because of the misfiring of a stapler and one
because of the impossibility to reduce a large hiatal her-
nia. In the MO group, there was only one conversion
because of massive adhesions.
Table 1 Demographic and clin-
ical data
SD standard deviation, ASA
American Society of Anesthesi-
ologists, BMI body mass index
Superobese (n041) Morbidly obese (n0247) P value
Gender
Male 17 (41.5 %) 56 (22.7 %) 0.02
Female 24 (58.5 %) 191 (77.3 %)
Age (years), mean ± SD 40.8±11 44±10.5 0.07
ASA score, mean ± SD 2.46±0.5 2±0.4 0.001
Initial BMI (kg/m2), mean ± SD 53.1±3 43±3.3 0.0001
Initial weight (kg), mean ± SD 150.3±17.3 118±15.6 0.0001
Comorbidities
Hypertension 16 (39 %) 79 (32 %) 0.38
Diabetes 9 (22 %) 46 (18.6 %) 0.67
Sleep obstructive apnea syndrome 8 (19.5 %) 60 (24.3 %) 0.56
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There was no difference concerning the intra-operative
complications (one in each group). There were a misfiring of
a stapler in the SO group as mentioned before and an intra-
operative perforation of the gastric pouch by the nasogastric
tube requiring a redo of the pouch by a robotic approach.
Concerning the early postoperative complications, the
overall rate was statistically similar in both groups (14.6
vs. 10.9 %; p00.44). In the SO group, we had six compli-
cations: one hypoxemia due to bilateral basal atelectasia,
one pneumonia, one anastomotic bleeding due to an ulcer
requiring endoscopic hemostasis, two pulmonary embolism,
and finally one mild dysesthesia interesting the arm. In the
MO group, 27 complications were recorded: 11 pulmonary
embolisms, three anastomotic edema that were successfully
treated conservatively, two atelectasias, two bacteremias,
two neurological complications (leg paresthesia), one hem-
orrhage on the stapled line requiring a reoperation, one
incisional hernia requiring a reoperation, one urinary infec-
tion, one superficial phlebitis, one hematemesis requiring an
endoscopy, one laryngeal edema, and one wound seroma.
The risk of pulmonary embolism was the same between
both groups (4.9 vs. 4.5 %; p01). There was only one late
stricture in the MO group treated by one session of endo-
scopic dilation and none in the SO group (p01). Of note,
there was no leak in the entire series.
We had one death in the MO group and none in the SO
group (p01). This 40-year-old lady was classified ASA 3
and had a BMI of 44. Her past medical history was signif-
icant for a coagulopathy, and unfortunately at postoperative
day 1 she presented a massive pulmonary embolism and a
complete bilateral carotid thrombus. She was immediately
treated by endovascular thromboaspiration. Unfortunately,
she developed a massive reperfusion cerebral edema and
passed away at postoperative day 2.
Finally, considering the functional results, the diminution
of BMI up to 1 year was seen to be satisfactory (Table 3;
Fig. 1). At 12 months, the SO group lost more unit of BMI
than the MO group (18.3 vs. 14.4; p00.0001). If we con-
sider only the percent of BMI loss at 12 months, there was
no difference between both groups. Not surprisingly, the
%EBMIL at 1 year was significantly higher for the MO
group than for the SO group.
Discussion
Today the surgical challenge that represents the SO popula-
tion remains real, even with the introduction of minimally
invasive surgery. Different procedures have been tried with
success. Sleeve gastrectomy, biliopancreatic diversion with
duodenal switch, and RYGB have all been reported as safe
and effective [1, 6–12]. Several data confirmed that bilio-
pancreatic diversion seems to be the most effective proce-
dure in the SO population [8, 9, 23], but with a higher
morbidity rate. Thus, the debate still exists [2, 24].
From a surgical point of view, SO remains a difficult
population to manage, usually with outcomes slightly less
favorable than for MO [6, 11]. SO patients tend to have a
thicker abdominal wall, greater amount of peri-visceral fat
in the abdominal cavity, and fatty infiltration of liver, all of
these facts leading to a more difficult operation [25]. In
addition, in the present study, the SO population had clearly
a higher ASA score and consisted in more male patients, as
already reported by others [11]. Male patients have been
seen as a more difficult group to operate on, especially
because of the distribution of fat (central obesity) [1, 25].
In addition, like others [11, 25], we did not notice any
difference of age between both groups, contradicting the
fact that weight gain is a continuum.
Table 2 Perioperative results
and short-term outcomes
SD standard deviation
Superobese (n041) Morbidly obese (n0247) P value
Operative time (min), mean ± SD 249.7±92.4 253±96.5 0.84
Conversion 2 (4.9 %) 1 (0.4 %) 0.05
Intra-operative complications 1 (2.4 %) 1 (0.4 %) 0.26
Postoperative complications 6 (14.6 %) 27 (10.9 %) 0.44
Mortality 0 (0 %) 1 (0.4 %) 1
Length of stay (days), mean ± SD 7±3.33 6±2.7 0.03
Table 3 Evolution of BMI and results at 1 year
Superobese
group
Morbidly
obese group
P
value
BMI loss at 1 month,
mean ± SD
6.3±2.11 4.5±1.4 0.0001
BMI loss at 3 months,
mean ± SD
12.6±8.8 8.6±2.3 0.0001
BMI loss at 6 months,
mean ± SD
14.5±3.9 11.1±2.7 0.0001
BMI loss at 12 months,
mean ± SD
18.3±4.4 14.4±3.3 0.0001
Percent BMI loss at
12 months, mean ± SD (%)
34±8 34±7 1
Percent excess BMI loss at
12 months, mean ± SD (%)
65±15 83±22 0.0007
BMI body mass index, SD standard deviation
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Wepresent herein one of the first series of robotic RYGBwith
a special focus on the outcomes for SO. This large comparative
study showed globally good results, with no anastomotic leak
after more than 280 patients. From a statistical point of view, we
found more conversion in the SO group when compared to the
MO group. On the other hand, in a comparative study between
super-superobese (BMI>60) and none super-superobese, Gould
et al. [25] found no statistical difference for the conversion rate.
The relation between BMI and conversion rate has been shown
for other indications [26], but for RYGB the relation is less clear
[27], though we had more conversion in the SO group, even if
the reasons that conducted to an open procedurewere not directly
related to the high BMI (technical problem with a stapler and
difficulty to reduce a hiatal hernia).
In addition, we found a longer length of stay for the SO group
(+1 day), yet from a clinical point of view, this difference is
minimal. The difference in terms of complications was maybe
more interesting though. Even if there was no statistical differ-
ence, the clinical difference is important with almost 50 % of
increased complication rate for SO. Interestingly, this complica-
tion rate is at least similar if not better than previously reported for
laparoscopic RYGB in SO [1, 9, 11, 12, 25, 28]. More specifi-
cally, Oliak et al. [28] reported a higher risk to develop gastroin-
testinal leak and postoperative complications when performing
laparoscopic RYGB for patients with BMI >60. Even if we
extrapolate these data to our SO population, we cannot confirm
these results because fortunately we had no leak so far.
There is no real consensus concerning the choice of the
procedure for SO. Globally, in critically morbid patients, a
sleeve gastrectomy can be considered as a first step in a two-
stage procedure [7] or can even be considered more and more
often as a single-stage procedure [29]. The outcomes reported
so far are encouraging, but only few data are available for the
long-term follow-up [30]. In a two-stage procedure, a duode-
nal switch (or a RYGB) is usually proposed, requiring ad-
vanced laparoscopic skills. The development of robotics was
seen as a real technological help in performing anastomosis
and complex dissection or reconstruction [31–33]. For bari-
atric surgery, the introduction of robotic technology has slow-
ly gained an increased interest, notably by obtaining better
outcomes. Very recently, the largest series of robot-assisted
RYGB reported a leak rate of 0.09 % [34]. In fact, this dual-
center study reported only one leak after 1,100 procedures
[34]. The gastrojejunal leak rate after laparoscopic RYGB is
classically higher with a range reported to be between 1 and
4 % [11, 14]. Several comparative series have clearly shown a
reduced anastomotic complication rate after RYGB [14, 15,
35]. Finally, in a systematic review, Markar and colleagues
[35] found a reduced incidence of anastomotic stricture with
the robotic approach when compared to laparoscopy.
However, robotic technology is often criticized for the longer
operative time associated to its use, even if this difference did not
reach a statistical significance in a recent systematic review [35].
In the present series, contrary to other laparoscopic series [11],
we have shown that there was no difference in terms of operative
time between both groups of patients, yet it can be considered
longer than previously reported for the laparoscopic approach [9,
11] but relatively similar to other robotic series [16, 36], with a
short learning curve [13].
The functional outcomes were also promising with similar
%BMI loss at 1 year between both groups. If other centers have
reported high weight loss failure rates following RYGB after a
long-term follow up [37], in our series we did not confirm this
fact so far, yet our follow-up is still short and requires long-term
outcomes. Suter et al. [11] have also compared SO and MO
after laparoscopic RYGB. They did find that many SO patients
remain in the severely obese or MO category, but with a
significant improvement in terms of quality of life. This fact
was confirmed by others as well [25], yet the quality of life was
beyond the scope of our study and we are not able to confirm
these data for the robotic approach.
This study has several limitations that deserve comments.
First, this is a comparative study between SO and MO, not
between the laparoscopic and robotic approach. The interest
on such a study could be important since the debate on the
real advantages of robotic technology continues [38], yet
this series is one of the first to evaluate specifically the value
of robotic RYGB for SO and the outcomes are more than
favorable. Then, economical evaluation was not carried on.
However, we already know from a precedent series that
reducing the anastomotic leak rate can reduce the cost when
using the robotic technology [14]. Finally, long-term follow-
up is still required before drawing definitive conclusions.
Conclusions
Robot-assisted RYGB can be performed safely for SO, with
low complication rates and satisfactory results at 1 year. These
results were comparable to MO, yet this approach for SO has
Fig. 1 Evolution of BMI loss between superobese (SO in blue) and
morbidly obese (MO in red) during 12 months
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been associated with significantly, even if limited, increased
conversion rate and length of stay. The real advantages in
comparison to the laparoscopic approach are still debated
and require further studies for this subpopulation of SO.
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